Prism Medico

Bengaluru, India Founded: 1985 • Age: 41 yrs Listed
Drugs for multiple therapeutic areas are manufactured through RD efforts.

About Prism Medico

Prism Medico is a publicly listed company based in Bengaluru (India) founded in 1985. Drugs for multiple therapeutic areas are manufactured through RD efforts. Its Indian entity Prism Medico And Pharmacy Limited reported revenue of ₹2.47 Cr. Its focus areas include Diversified Pharmaceuticals and Drugs.

Company details

Prism Medico was established in 1985 and is headquartered in Bengaluru, India. Operations center on research and development within the pharmaceutical sector, where drugs are produced for diverse therapeutic areas. Manufacturing processes are managed to support various medical needs, with activities conducted primarily from the Indian base. The companys domain, prismmedico.in, facilitates online presence for industry engagement.

  • Headquarters Bengaluru, India
  • Stage Public
  • Sectors
    Healthcare
  • Website prismmedico.in
  • Legal Name Prism Medico & Pharmacy Ltd.
Key Metrics
  • Market Cap
    ₹47.44 Cr

    PRISMMEDI · BSE

  • Share Price
    ₹35.00

    +0.06% today

  • Revenue
    ₹54.43 Cr

    FY 2018-19 · +138.7% YoY

  • EBITDA
    ₹0.12 Cr

    Margin 0.2%

  • Net Profit
    ₹0.16 Cr

    FY 2018-19 · +633.3% YoY

  • ROE
    1.1%

    ROCE 1.6%

  • Debt / Equity
    0.17

    Interest cover -42.3x

Board of directors of Prism Medico And Pharmacy Limited (Prism Medico)

Prism Medico And Pharmacy Limited is the primary company behind Prism Medico. The board of Prism Medico And Pharmacy Limited currently have 4 directors; the longest-serving is Davender Singh, appointed in 2022. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Davender Singh
DIN 09447213
Director31 Jan 20224 yrs 9 moPrism Medico And Pharmacy Limited
Pardeep Kumar
DIN 09451568
Director31 Jan 20224 yrs 9 moPrism Medico And Pharmacy Limited
Sakshi Laller
DIN 10163397
Whole-time director16 May 20233 yrs 6 moPrism Medico And Pharmacy Limited
Dinesh Kumar
DIN 01149388
Director14 Aug 20233 yrs 3 moPrism Medico And Pharmacy Limited

IPO & Listings of Prism Medico

Prism Medico is a publicly listed company on the BSE with ticker symbol PRISMMEDI in India, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date23 Oct 1985
  • Listed onBSE: 512217
  • Listed entityPrism Medico & Pharmacy Ltd.
  • Exchange sectorFinance
  • ISININE730E01016
  • Share price₹31.99 (+1.39% on the day) · 2026-10-14
  • Market capitalisation₹42.8 Cr
  • Price to earnings17.6
  • EPS (diluted, trailing year)₹-0.60
  • Volume (last session)22,014

Financials of Prism Medico

Exchange-reported figures of Prism Medico And Pharmacy Limited, the listed company behind Prism Medico (BSE: PRISMMEDI).

Financial Highlights

FY 2018-19 · Consolidated
Revenue
₹54.43 Cr
+138.7% YoY
EBITDA
₹0.12 Cr
-84.2% YoY
Profit After Tax
₹0.16 Cr
+633.3% YoY
Net Worth
₹12.91 Cr
+0.3% YoY
Total Assets
₹15.21 Cr
+0.9% YoY
Total Debt
₹2.27 Cr
+4.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2018-19FY 2017-18FY 2016-17
Income statement
Revenue54.4322.805.27
Revenue growth+138.7%+332.6%-
EBITDA0.120.760.07
EBITDA margin+0.2%+3.3%+1.3%
Profit before tax(0.07)0.06(0.21)
Net profit0.16(0.03)(0.22)
Net profit margin+0.3%-0.1%-4.2%
EPS (₹)0.070.000.00
Balance sheet
Total assets15.2115.0716.38
Net worth12.9112.8712.87
Total debt2.272.183.50
Cash & bank0.411.361.95
Net working capital4.853.186.42
Cash flow
Cash from operations(0.44)3.550.00
Cash from investing0.00(2.53)0.00
Cash from financing(0.50)(1.61)0.00
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue2.440.632.931.278.4416.7626.89
Revenue growth+287.3%-78.5%+130.7%-85.0%-49.6%-37.7%-
EBITDA0.41(0.08)(0.13)(0.10)(0.50)(0.17)(0.05)
EBITDA margin+16.8%-12.7%-4.4%-7.9%-5.9%-1.0%-0.2%
Profit before tax0.44(0.06)(0.03)(0.11)(0.51)(0.18)(0.07)
Net profit0.33(0.04)(0.02)(0.08)(0.38)(0.13)(0.05)
Net profit margin+13.5%-6.4%-0.7%-6.3%-4.5%-0.8%-0.2%
EPS (₹)0.53(0.08)(0.04)(0.13)(0.61)(0.21)(0.08)
Balance sheet
Total assets15.4115.0915.1415.1612.5512.9313.06
Net worth15.4115.0915.1415.1612.5512.9213.05
Total debt0.000.000.000.000.000.000.00
Cash & bank0.060.070.080.100.060.080.11
Net working capital15.2514.8314.8914.9212.3210.8611.04
Cash flow
Cash from operations0.00(0.02)(0.01)2.95(2.38)(0.05)(4.36)
Cash from investing0.000.000.00(2.91)2.350.024.36
Cash from financing0.000.00(0.01)0.000.000.000.00
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue0.180.000.280.070.501.590.070.21
Revenue growth (YoY)-64.0%-100.0%+300.0%-66.7%+72.4%+2550.0%--
Other income0.260.090.000.010.020.000.010.00
Total expenses0.220.150.410.090.600.940.060.22
EBITDA(0.04)(0.15)(0.13)(0.02)(0.10)0.650.01(0.01)
EBITDA margin-22.2%--46.4%-28.6%-20.0%+40.9%+14.3%-4.8%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax0.22(0.06)(0.13)(0.01)(0.08)0.650.02(0.01)
Tax0.000.000.120.000.00(0.01)(0.02)0.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 16 Nov 2026
ParticularsFY 2018-19FY 2017-18FY 2016-17
Revenue54.4322.805.27
Revenue growth+138.7%+332.6%-
Other income0.300.040.07
Total expenses54.3122.045.20
Employee cost0.270.210.28
EBITDA0.120.760.07
EBITDA margin+0.2%+3.3%+1.3%
Depreciation0.380.450.21
Interest0.110.290.14
Profit before tax(0.07)0.06(0.21)
Tax(0.13)0.070.01
Net profit0.16(0.03)(0.22)
Net profit margin+0.3%-0.1%-4.2%
EPS (₹)0.070.000.00
ParticularsFY 2018-19FY 2017-18FY 2016-17
Equity & liabilities
Share capital6.066.066.06
Reserves & surplus6.856.816.81
Shareholders' funds (net worth)12.9112.8712.87
Minority interest0.000.000.00
Secured loans2.271.250.27
Unsecured loans0.000.933.23
Total debt2.272.183.50
Total liabilities15.2115.0716.38
Assets
Gross block10.2210.2310.44
Net block8.919.319.91
Capital work in progress0.000.000.00
Investments1.362.610.00
Inventories1.391.493.41
Sundry debtors3.130.000.71
Cash & bank balances0.411.361.95
Loans & advances5.920.981.23
Total current assets10.853.837.30
Total current liabilities6.000.650.88
Net working capital4.853.186.42
Total assets15.2115.0716.38
ParticularsFY 2018-19FY 2017-18FY 2016-17
Opening cash1.351.950.00
Net cash from operating activities(0.44)3.550.00
Net cash from investing activities0.00(2.53)0.00
Net cash from financing activities(0.50)(1.61)0.00
Net change in cash(0.95)(0.59)0.00
Closing cash0.411.361.95
ParticularsFY 2018-19FY 2017-18FY 2016-17
Growth
Sales growth+138.7%+332.6%-
EBITDA growth-84.2%+985.7%-
PBT growth-+9998.0%+9997.0%
Net income growth+633.3%+86.4%-
Profitability & leverage
Net income margin+0.1%-0.0%-4.2%
Return on capital employed+1.6%+2.8%-0.4%
Return on net worth+1.1%-0.2%-1.7%
Debt / equity0.170.220.27
Long-term debt / equity0.000.120.23
Interest cover-42.3193.55-100.00
Efficiency & per share
Fixed asset turnover5.322.210.53
Inventory turnover37.809.311.64
Debtors turnover34.7864.237.86
EPS (₹)0.070.000.00
Dividend per share (₹)0.000.000.00
Book value per share (₹)21.2921.2321.24
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue0.180.000.280.070.501.590.070.21
Revenue growth (YoY)-64.0%-100.0%+300.0%-66.7%+72.4%+2550.0%--
Other income0.260.090.000.010.020.000.010.00
Total expenses0.220.150.410.090.600.940.060.22
EBITDA(0.04)(0.15)(0.13)(0.02)(0.10)0.650.01(0.01)
EBITDA margin-22.2%--46.4%-28.6%-20.0%+40.9%+14.3%-4.8%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax0.22(0.06)(0.13)(0.01)(0.08)0.650.02(0.01)
Tax0.000.000.120.000.00(0.01)(0.02)0.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue2.440.632.931.278.4416.7626.89
Revenue growth+287.3%-78.5%+130.7%-85.0%-49.6%-37.7%-
Other income0.030.020.120.000.000.000.00
Total expenses2.030.713.061.378.9416.9326.94
Employee cost0.060.040.030.050.190.170.22
EBITDA0.41(0.08)(0.13)(0.10)(0.50)(0.17)(0.05)
EBITDA margin+16.8%-12.7%-4.4%-7.9%-5.9%-1.0%-0.2%
Depreciation0.000.000.010.010.010.010.02
Interest0.000.000.010.000.000.000.00
Profit before tax0.44(0.06)(0.03)(0.11)(0.51)(0.18)(0.07)
Tax0.11(0.02)(0.01)(0.03)(0.13)(0.05)(0.02)
Net profit0.33(0.04)(0.02)(0.08)(0.38)(0.13)(0.05)
Net profit margin+13.5%-6.4%-0.7%-6.3%-4.5%-0.8%-0.2%
EPS (₹)0.53(0.08)(0.04)(0.13)(0.61)(0.21)(0.08)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital6.066.066.066.066.066.066.06
Reserves & surplus9.359.039.089.106.496.866.99
Shareholders' funds (net worth)15.4115.0915.1415.1612.5512.9213.05
Secured loans0.000.000.000.000.000.000.00
Unsecured loans0.000.000.000.000.000.000.00
Total debt0.000.000.000.000.000.000.00
Total liabilities15.4115.0915.1415.1612.5512.9313.06
Assets
Gross block0.030.030.030.030.050.220.22
Net block0.030.030.030.030.050.060.07
Capital work in progress0.000.000.000.000.000.000.00
Investments0.000.000.000.000.001.941.94
Inventories6.776.776.776.776.774.850.05
Sundry debtors3.933.583.694.764.8813.5118.34
Cash & bank balances0.060.070.080.100.060.080.11
Loans & advances4.694.884.453.520.631.041.07
Total current assets15.4515.3014.9915.1512.3419.4819.57
Total current liabilities0.200.470.100.230.028.628.53
Net working capital15.2514.8314.8914.9212.3210.8611.04
Total assets15.4115.0915.1415.1612.5512.9313.06
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.070.080.100.060.080.110.12
Net cash from operating activities0.00(0.02)(0.01)2.95(2.38)(0.05)(4.36)
Net cash from investing activities0.000.000.00(2.91)2.350.024.36
Net cash from financing activities0.000.00(0.01)0.000.000.000.00
Net change in cash0.00(0.02)(0.01)0.04(0.03)(0.03)(0.01)
Closing cash0.060.070.080.100.060.080.11
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+287.3%-78.5%+130.7%-85.0%-49.6%-37.7%-
EBITDA growth+612.5%+38.5%-30.0%+80.0%-194.1%-240.0%-
PBT growth+9998.0%-100.0%+72.7%+78.4%-183.3%-157.1%-
Net income growth+925.0%-100.0%+75.0%+79.0%-192.3%-160.0%-
Revenue CAGR (3Y)+24.3%-57.9%-44.1%-63.9%-38.5%-7.2%+568.5%
EBITDA CAGR (3Y)--45.7%-8.6%+26.0%---43.7%
Profitability & leverage
Net income margin+13.5%-6.4%-0.7%-6.3%-4.5%-0.8%-0.2%
Return on capital employed+2.8%-0.5%-0.1%-0.8%-3.9%-1.4%-0.5%
Return on net worth+2.1%-0.3%-0.1%-0.6%-2.9%-1.0%-0.4%
Debt / equity0.000.000.000.000.000.000.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover0.000.00-7.140.000.000.000.00
Efficiency & per share
Fixed asset turnover81.3321.0097.6731.7562.5276.18122.23
Inventory turnover0.360.090.430.191.456.8453.25
Debtors turnover0.650.170.690.260.921.052.43
EPS (₹)0.53(0.08)(0.04)(0.13)(0.61)(0.21)(0.08)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)25.4224.8924.9725.0120.7121.3221.53
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Prism Medico

Premium access

Complete news archive for Prism Medico

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prism Medico

Prism Medico was founded in 1985.

Prism Medico is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

The primary company behind Prism Medico, Prism Medico And Pharmacy Limited, reported revenue of ₹2.47 Cr for FY 2026, up 287% year on year.

Prism Medico was established in 1985 and is headquartered in Bengaluru, India. Operations center on research and development within the pharmaceutical sector, where drugs are produced for diverse therapeutic areas. Manufacturing processes are managed to support various medical needs, with activities conducted primarily from the Indian base. The companys domain, prismmedico.in, facilitates online presence for industry engagement.

Yes, Prism Medico is publicly traded on BSE under the ticker symbol PRISMMEDI.

Prism Medico operates through Prism Medico And Pharmacy Limited.

The legal entities of Prism Medico currently have 6 directors, including Davender Singh, Pardeep Kumar, Sameer Gupta and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available